Guangdong Lifestrong Pharmacy301111.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Guangdong Lifestrong Pharmacy (301111.SZ) trades at a P/E of 525.00x, P/B of 4.18x, P/S of 10.70x, and a dividend yield of 0.26%.
Longitudinal percentile comparison: P/E sits at the 86th percentile over the trailing 10Y window (vs. 71st percentile over 3Y); P/B sits at the 48th percentile over the trailing 10Y window (vs. 65th percentile over 3Y); P/S sits at the 49th percentile over the trailing 10Y window (vs. 62nd percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 98th percentile within its industry and the 97th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.26%, ranking at the 20th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 37.8 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Guangdong Lifestrong Pharmacy operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 301111 · SZSE: 301111 · 301111
Want the full picture on whether Guangdong Lifestrong Pharmacy (301111.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 525.00 | ||||||
| P/B (MRQ) | 4.18 | ||||||
| P/S (TTM) | 10.70 | ||||||
| Dividend Yield | 0.26% | ||||||
| Buyback + Div Yield | 0.26% |